These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22878569)

  • 1. [Pharmacological studies for the ameliorative effects of yokukansan on memory deficits and abnormal behavior in an animal model of dementia].
    Iwasaki K; Takasaki K; Nogami A; Kubota K; Katsurabayashi S; Mishima K; Fujiwara M
    Nihon Yakurigaku Zasshi; 2012 Aug; 140(2):66-70. PubMed ID: 22878569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological study of the amerliorative effects of Yokukansan on memory impairment and the behavioral and psychological symptoms of dementia in AD models].
    Kubota K; Nogami A; Takasaki K; Katsurabayashi S; Mishima K; Fujiwara M; Iwasaki K
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):110-4. PubMed ID: 24614632
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.
    Ikarashi Y; Iizuka S; Imamura S; Yamaguchi T; Sekiguchi K; Kanno H; Kawakami Z; Yuzurihara M; Kase Y; Takeda S
    Biol Pharm Bull; 2009 Oct; 32(10):1701-9. PubMed ID: 19801831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
    Kung FC; Ishii R; Liu HC; Takeda M
    Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorative effects of yokukansan on behavioral deficits in a gerbil model of global cerebral ischemia.
    Liu Y; Nakamura T; Toyoshima T; Lu F; Sumitani K; Shinomiya A; Keep RF; Yamamoto T; Tamiya T; Itano T
    Brain Res; 2014 Jan; 1543():300-7. PubMed ID: 24269335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia.
    Nogami A; Sakata Y; Uchida N; Yamaguchi K; Kawasaki C; Shindo T; Kubota K; Katsurabayashi S; Takasaki K; Mishima K; Nishimura R; Fujiwara M; Iwasaki K
    J Nat Med; 2011 Apr; 65(2):275-81. PubMed ID: 21152992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effect of traditional Japanese medicine yokukansan on age-related impairments of working memory and reversal learning in rats.
    Mizoguchi K; Shoji H; Tanaka Y; Tabira T
    Neuroscience; 2011 Mar; 177():127-37. PubMed ID: 21195139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clarifying evidence of pharmacological effects of Kampo medicine].
    Iwasaki K
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):53-4. PubMed ID: 24761471
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic involvement and synaptic dynamin 1 expression in Yokukansan-mediated improvement of spatial memory in a rat model of early Alzheimer's disease.
    Uchida N; Takasaki K; Sakata Y; Nogami A; Oishi H; Watanabe T; Shindo T; Egashira N; Kubota K; Katsurabayashi S; Mishima K; Fujiwara M; Nishimura R; Iwasaki K
    Phytother Res; 2013 Jul; 27(7):966-72. PubMed ID: 22888033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence.
    Matsumoto K; Zhao Q; Niu Y; Fujiwara H; Tanaka K; Sasaki-Hamada S; Oka J
    J Pharmacol Sci; 2013; 122(4):257-69. PubMed ID: 23883485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
    Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K
    J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning over a new leaf: Ginkgo biloba in prevention of dementia?
    DeKosky ST; Furberg CD
    Neurology; 2008 May; 70(19 Pt 2):1730-1. PubMed ID: 18458215
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmaco-therapy of behavioral and psychological symptoms of dementia].
    Arai H
    Nihon Ronen Igakkai Zasshi; 2006 Sep; 43(5):549-53. PubMed ID: 17073274
    [No Abstract]   [Full Text] [Related]  

  • 15. The Japanese Angelica acutiloba root and yokukansan increase hippocampal acetylcholine level, prevent apoptosis and improve memory in a rat model of repeated cerebral ischemia.
    Nogami-Hara A; Nagao M; Takasaki K; Egashira N; Fujikawa R; Kubota K; Watanabe T; Katsurabayashi S; Hatip FB; Hatip-Al-Khatib I; Iwasaki K
    J Ethnopharmacol; 2018 Mar; 214():190-196. PubMed ID: 29269276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kamikihito improves memory dysfunction in Alzheimer's disease].
    Tohda C; Watari H
    Nihon Yakurigaku Zasshi; 2015 May; 145(5):224-8. PubMed ID: 25958908
    [No Abstract]   [Full Text] [Related]  

  • 17. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials.
    Matsuda Y; Kishi T; Shibayama H; Iwata N
    Hum Psychopharmacol; 2013 Jan; 28(1):80-6. PubMed ID: 23359469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol extract of Astragali Radix and Salviae Miltiorrhizae Radix, Myelophil, exerts anti-amnesic effect in a mouse model of scopolamine-induced memory deficits.
    Lee JS; Kim HG; Han JM; Kim DW; Yi MH; Son SW; Kim YA; Lee JS; Choi MK; Son CG
    J Ethnopharmacol; 2014 May; 153(3):782-92. PubMed ID: 24690775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.